Evidence map›Paper›PMID 28132121›Full record

ArticleJournal of autism and developmental disorders2017

Assessment of Caregiver Inventory for Rett Syndrome.

Jane B Lane, Amber R Salter, Nancy E Jones, Gary Cutter, Joseph Horrigan, Steve A Skinner, Walter E Kaufmann, Daniel G Glaze, Jeffrey L Neul, Alan K Percy

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of autism and developmental disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02738281 (Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02738281 completednot on this map

Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2015 to 2021Enrolled1,044ConditionsRett Syndrome, MECP2 Duplication dIsorder, CDKL5 Disorder, FOXG1 Syndrome
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Rett syndrome: The Natural History Study journey.Annals of the Child Neurology Society · 2024
    Review
  9. Article
  10. Article
  11. Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  12. Article
  13. Drug Studies on Rett Syndrome: From Bench to Bedside.Journal of autism and developmental disorders · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Jane B LaneCivitan International Research Center, University of Alabama at Birmingham, 1720 2nd Avenue South, CIRC 320E, Birmingham, AL, 35294-0021, USA.
Amber R SalterSchool of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Nancy E JonesNeuren Pharmaceuticals, Camberwell, Australia.
Gary CutterSchool of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Joseph HorriganDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.
Steve A SkinnerGreenwood Genetic Center, Greenwood, SC, USA.
Walter E KaufmannGreenwood Genetic Center, Greenwood, SC, USA.
Daniel G GlazeDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Jeffrey L NeulDepartment of Neuroscience, University of California San Diego, La Jolla, CA, USA.
Alan K PercyCivitan International Research Center, University of Alabama at Birmingham, 1720 2nd Avenue South, CIRC 320E, Birmingham, AL, 35294-0021, USA. apercy@uab.edu.
University of Alabama at Birmingham · USGreenwood Genetic Center · USBaylor College of Medicine · USCivitan International · USUniversity of California, San Diego · USUniversity of North Carolina at Chapel Hill · US

Funding

Training and Career Development ComponentU54HD061222 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PERCY, ALAN KENNETH · 2009 to 2019
$12.4M
NICHD NIH HHS U54 HD061222
6 · The paper itself

Abstract

Rett syndrome (RTT) requires total caregiver attention and leads to potential difficulties throughout life. The Caregiver Burden Inventory, designed for Alzheimer disease, was modified to a RTT Caregiver Inventory Assessment (RTT CIA). Reliability and face, construct, and concurrent validity were assessed in caregivers of individuals with RTT. Chi square or Fisher's exact test for categorical variables and t tests or Wilcoxon two-sample tests for continuous variables were utilized. Survey completed by 198 caregivers; 70 caregivers completed follow-up assessment. Exploratory factor analysis revealed good agreement for physical burden, emotional burden, and social burden. Internal reliability was high (Cronbach's alpha 0.898). RTT CIA represents a reliable and valid measure, providing a needed metric of caregiver burden in this disorder.

Indexed as

Adaptation, PsychologicalAdultCaregiversEmotionsFemaleFollow-Up StudiesHumansMaleMiddle AgedReproducibility of ResultsRett SyndromeSurveys and QuestionnairesCaregiver InventoryFactor analysisMECP2Rett syndrome

Identifiers

PMID28132121
PMCPMC5357458
OpenAlexW2582534361

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.